Labeling mesenchymal stem cells in the heart with superparamagnetic iron oxide nanoparticles in vitro and tracking after implantation with MRI in vivo

GU Yu-mei,ZHU Wei,WEI Meng

DOI: https://doi.org/10.3969/j.issn.1006-5725.2009.02.007

2009-01-01

Abstract:Objective To explore whether superparamaganetic iron oxide nanoparticles (SPIO) can be used as a tracer for tracking the implanted mesenchymal stem cells(MSCs) in the infarct border zone under MRI scanning. Methods MSCs were cultured in vitro, labeled with SPIO, and then stained with Prussian blue to assess the rate of the labeling cells. MTT assay was used to investigate the effect of SPIO on the viability of MSCs. The rat model of acute myocardial infarction was established and then the rats were assigned to receive injections of MSCs with or without SPIO labeling (magnetic cell group and non-magnetic cell group), or injections of SPIO (SPIO group) to the infarct border zone at different points. MRI scanning was performed at days 3, 7, 14, and 21 after injection, the cardiac tissues were then histologically examined. Results 95% of the MSCs were successfully labeled with SPIO. No adverse effect of SPIO on the viability and differentiation of MSCs was found. T2 hypointense signal was detectable in 65.6% of injection points at day 3, 56.3% at day 7, and 18.8% at day 14, and became undetectable at day 21. The hypointense zones were enlarged with poorly defined borders and the signal contrast was decreased in a time-dependent manner. Conclusion SPIO can be used as a tracer for tracking the implanted MSCs in the infarct border zone under MRI scanning.